European Biobanking and BioMolecular resources Research Infrastructure

European Biobanking and BioMolecular resources Research Infrastructure
Name	European Biobanking and BioMolecular resources Research Infrastructure
Abbreviation	BBMRI-ERIC
Formation	2013
Type	Research infrastructure (ERIC)
Headquarters	Groningen
Region served	European Union
Membership	Member States, Associated Countries

European Biobanking and BioMolecular resources Research Infrastructure is a pan-European research infrastructure that coordinates biobank networks and biomolecular resources to support biomedical research and public health across Europe. It links national initiatives, academic centers, and international projects to enable transnational access to biological samples, omics data, and standardized protocols for researchers in fields including genomics, metabolomics, proteomics, and epidemiology. BBMRI-ERIC fosters collaborations among institutions such as European Molecular Biology Laboratory, Wellcome Trust Sanger Institute, Karolinska Institutet, and Institut Pasteur to accelerate research on rare diseases, cancer, neurodegeneration, and infectious diseases.

Overview and Mission

BBMRI-ERIC's mission is to provide a sustainable, interoperable infrastructure for biobanks and biomolecular resources that supports research initiatives like Human Genome Project, International HapMap Project, 1000 Genomes Project, European Genome-phenome Archive, and Horizon 2020. It aims to harmonize standards used by institutions such as Max Planck Society, CNRS, Karolinska Institutet, and University of Cambridge to enable sample sharing among consortia including International Cancer Genome Consortium, Global Alliance for Genomics and Health, and European Reference Networks. Key goals include ensuring sample quality, legal compliance across jurisdictions like Germany, France, Italy, and Spain, and promoting access for stakeholders such as European Commission, European Medicines Agency, World Health Organization, and national research funders.

History and Development

BBMRI-ERIC was preceded by initiatives such as the BBMRI preparatory phase, funded under Seventh Framework Programme, and built on earlier networks linked to European Strategy Forum on Research Infrastructures and projects associated with European Molecular Biology Organization. Founding momentum came from collaborations among institutions including Karolinska Institutet, Leiden University Medical Center, University of Tartu, and University of Milan. Key historical milestones paralleled policy developments at European Commission levels and major research milestones like the launch of Horizon 2020 and establishment of ERIC frameworks similar to European Spallation Source and European XFEL. The establishment consolidated practices from networks such as BBMRI-LPC and coordinated with initiatives like Islet Transplantation Consortium and International Rare Diseases Research Consortium.

Structure and Governance

BBMRI-ERIC operates under the European Research Infrastructure Consortium legal form with a statutory governance model involving a General Assembly of member states, a Director General, and a Scientific Committee that includes representatives from universities such as Utrecht University, Oxford University, Heidelberg University, and Trinity College Dublin. Administrative bodies liaise with regulatory agencies including European Data Protection Supervisor and national authorities in countries like Sweden, Estonia, Netherlands, and Belgium. Strategic partnerships with organizations such as European Bioinformatics Institute, European Centre for Disease Prevention and Control, and Biobanking and BioMolecular resources Research Infrastructure - Luxembourg inform policy, and advisory boards draw expertise from institutions such as Harvard Medical School, Johns Hopkins University, and Karolinska Institutet.

Services and Facilities

Services include federated catalogue access, sample locator tools, quality management systems, and training programs delivered in collaboration with ELIXIR, EBI, CERN-linked data services, and national biobanks like Finnish Institute for Health and Welfare and Estonian Biobank. Facilities supported range from clinical biobanks at Charité – Universitätsmedizin Berlin and Centre Hospitalier Universitaire de Lille to population cohorts such as UK Biobank, LifeLines, HUNT Study, and The Rotterdam Study. BBMRI-ERIC provides tools for standardized informed consent templates, sample processing SOPs, and data harmonization workflows compatible with repositories like European Genome-phenome Archive and platforms used by European Union Agency for Cybersecurity-aligned partners.

Research Programs and Collaborations

BBMRI-ERIC partners with major consortia including International Cancer Genome Consortium, European Joint Programme on Rare Diseases, European Human Biomonitoring Initiative, and projects under Horizon Europe and COST actions. Collaborative research spans translational projects with pharmaceutical partners such as GlaxoSmithKline, Roche, and Novo Nordisk and academic networks like EuroBioBank and BBMRI-ERIC National Nodes. It supports disease-focused initiatives including Alzheimer's Disease Neuroimaging Initiative, European Prospective Investigation into Cancer and Nutrition, and infectious disease consortia that collaborate with European Centre for Disease Prevention and Control and WHO Regional Office for Europe.

Funding and Membership

Funding streams include contributions from member states, grants from EU programs such as Horizon 2020 and Horizon Europe, and collaborative funding with agencies like European Research Council and national funders including National Institutes of Health-partnered programs. Membership comprises EU member states and associated countries, with institutional partners ranging from national biobanks like Istituto Superiore di Sanità and Institut Pasteur to research infrastructures such as ELIXIR and EATRIS. BBMRI-ERIC’s budgetary decisions are reviewed by delegates from entities such as Ministry of Education (Netherlands), Ministry of Health (Italy), and research councils including UKRI (prior to changes), assuring national oversight.

Impact and Ethical, Legal, and Social Issues

BBMRI-ERIC has influenced research output in areas covered by major publications tied to Nature, Science, The Lancet, and Nature Genetics by enabling cross-border sample sharing and large-scale studies like those associated with UK Biobank and International HapMap Project. Ethical, legal, and social issues are managed in dialogue with bodies such as European Data Protection Supervisor, Council of Europe (including the Convention on Human Rights and Biomedicine), and national ethics committees in countries like Germany and France. Debates involve consent models influenced by cases such as Edwards v. UK-style jurisprudence, data protection frameworks reminiscent of General Data Protection Regulation, and benefit-sharing discussions informed by precedents like Nagoya Protocol and advisory input from organizations such as Council of Europe and World Health Organization.

Category:Research infrastructures in Europe